AGENDA AT A GLANCE
8:30
Registration & Coffee
Unlocking Commercial Success in DACH’s Cell & Gene Therapy
9:50
Reserved for Solution Provider
10:20
Networking Break
10:45
Roundtable Discussions
- Commercialisation CART Ts
- Automation in Autologous Cell Therapy Manufacturing
- Standardization of MSC Clinical Trials for Commercial Success
- Strategic Approaches for Successful Gene Therapy Launches
- The Importance of a Holistic CMC Approach Early in the Pre-clinical Phase for Small Gene Therapy Biotechs
11:45
Key Takeaways
12:00
Lunch Break
Overcoming Bottlenecks in Viral Vector Manufacturing
13:25
Reserved for Solution Provider
14:30
Networking Break
Decentralized Production for Next-Gen Cell & Gene Therapies
15:25
Real-Time Monitoring & Control Systems in Automated CGT Workflows
16:00
Roundtable Discussions
- How Far Can We Push Automation in CGT Without Losing Flexibility?
- Best Practices for Scaling Autologous Therapies: What's Working Today?
- Building the Ideal CGT Manufacturing Facility: Modular vs. Custom Design
- Ensuring GMP Compliance in Closed System Environments
- Raw Material Standardization and Vendor Qualification in CGT
17:00
Key Takeaways
17:15
END OF DAY 1
8:30
Registration & Coffee
Quality Assurance in CGT
9:50
Reserved for Solution Provider
10:20
Networking Break
Novel Purification & Intensification Strategies
11:10
Reserved for Solution Provider
12:00
Lunch Break
Manufacturing Innovations for Allogeneic and In Vivo Therapies
14:15
Networking Break
Smart Factories: The Role of Digitalization & AI
15:10
Harnessing MES and Digital Batch Records to Strengthen CGT GMP Compliance
16:30
Chairman’s Closing Rearks
16:30
END OF CONFERENCE
